BayMark Health Services Acquires Los Angeles Area Opioid Treatment Program

The seventh in the LA Area, BayMark’s first facility in the San Fernando Valley provides medication-assisted treatment and counseling for opioid addiction.

BayMark Health Services announced the acquisition of Narcotic Addiction Treatment Agency (NATA), an Opioid Treatment Program (OTP) in Sun Valley, CA. Providing medication-assisted treatment (MAT) in the San Fernando Valley for more than 35 years, NATA has established themselves as a key provider of comprehensive treatment for opioid addiction in a professional and compassionate environment.  The NATA program will join six established BayMark-owned programs in the Greater Los Angeles area.

NATA provides outpatient methadone maintenance and detoxification combined with substance use counseling and behavioral therapies. This evidence-based approach is individualized to meet the needs of each patient. Additional services include addiction and relapse education, coordinated treatment during pregnancy, in-house lab services and referrals to community resources to assist patients in rebuilding their lives.

David K. White, Ph.D., Chief Executive Officer of BayMark Health Services, said, “While California is a leader in affordable, accessible opioid use disorder (OUD) treatment, there is still a need to expand and enhance those services in response to the unabating opioid crisis. BayMark has a significant presence in the State and is pleased to continue growing that footprint to provide services to Californians in need of help.”

Medication-assisted treatment reduces the symptoms of opioid withdrawal and cravings, paving the way for patients to focus on addressing the underlying causes of their addiction and supporting them to regain stability in their lives. Opioid treatment programs offer a proven alternative to residential or abstinence-based treatment models for OUDs.

For more information on BayMark Health Services visit:  www.BayMark.com.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to 53,000+ patients in recovery from substance use disorder across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.

The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.